Sonnet BioTherapeutics
SONN
SONN
10 hedge funds and large institutions have $921K invested in Sonnet BioTherapeutics in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 5 closing their positions.
Holders
10
Holders Change
–
Holders Change %
0%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
BlackRock
New York
|
$881K |
2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$16K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$16K |
4 |
RFA
4
Reilly Financial Advisors
La Mesa,
California
|
$8K |